A detailed history of Parallel Advisors, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,216 shares of TNDM stock, worth $43,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,216
Previous 1,307 6.96%
Holding current value
$43,155
Previous $52,000 1.92%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$35.21 - $47.3 $3,204 - $4,304
-91 Reduced 6.96%
1,216 $51,000
Q2 2024

Aug 08, 2024

BUY
$30.43 - $53.43 $3,377 - $5,930
111 Added 9.28%
1,307 $52,000
Q1 2024

May 06, 2024

BUY
$22.09 - $35.41 $14,623 - $23,441
662 Added 123.97%
1,196 $42,000
Q4 2023

Feb 09, 2024

BUY
$14.28 - $31.03 $6,740 - $14,646
472 Added 761.29%
534 $15,000
Q3 2023

May 20, 2024

BUY
$19.33 - $36.22 $386 - $724
20 Added 47.62%
62 $1,000
Q3 2023

Nov 13, 2023

BUY
$19.33 - $36.22 $386 - $724
20 Added 47.62%
62 $1,000
Q2 2023

May 20, 2024

SELL
$24.18 - $42.46 $241 - $424
-10 Reduced 19.23%
42 $1,000
Q2 2023

Aug 04, 2023

SELL
$24.18 - $42.46 $241 - $424
-10 Reduced 19.23%
42 $1,000
Q1 2023

May 20, 2024

SELL
$35.86 - $46.5 $41,023 - $53,196
-1,144 Reduced 95.65%
52 $2,000
Q1 2023

Apr 25, 2023

SELL
$35.86 - $46.5 $6,203 - $8,044
-173 Reduced 76.89%
52 $2,000
Q4 2022

Feb 03, 2023

SELL
$35.49 - $56.15 $3,619 - $5,727
-102 Reduced 31.19%
225 $10,000
Q3 2022

Nov 10, 2022

BUY
$43.76 - $68.97 $4,332 - $6,828
99 Added 43.42%
327 $16,000
Q2 2022

Aug 01, 2022

BUY
$53.22 - $123.09 $8,461 - $19,571
159 Added 230.43%
228 $13,000
Q1 2022

Apr 28, 2022

BUY
$101.89 - $150.09 $5,705 - $8,405
56 Added 430.77%
69 $8,000
Q4 2021

Jan 20, 2022

BUY
$118.18 - $153.21 $1,536 - $1,991
13 New
13 $2,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.28B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.